Microorganisms are crucial for human survival in view
of both mutualistic
and pathogen interactions. The control of the balance could be achieved
by use of the antibiotics. There is a continuous arms race that exists
between the pathogen and the antibiotics. The emergence of multidrug-resistant
(MDR) bacteria threatens health even for insignificant injuries. However,
the discovery of new antibiotics is not a fast process, and the healthcare
system will suffer if the evolution of MDR lingers in its current
frequency. The cationic photosensitizers (PSs) provide a unique approach
to develop novel, light-inducible antimicrobial drugs. Here, we examine
the antimicrobial activity of innovative selenophene-modified boron
dipyrromethene (BODIPY)-based PSs on a variety of Gram (+) and Gram
(−) bacteria. The candidates demonstrate a level of confidence
in both light-dependent and independent inhibition of bacterial growth.
Among them, selenophene conjugated PS candidates (BOD-Se and BOD-Se-I)
are promising agents to induce photodynamic inhibition (PDI) on all
experimented bacteria:
E. coli
,
S. aureus
,
B. cereus
, and
P. aeruginosa
. Further characterizations
revealed that photocleavage ability on DNA molecules could be potentially
advantageous over extracellular DNA possessing biofilm-forming bacteria
such as
B. cereus
and
P. aeruginosa
. Microscopy analysis with fluorescent
BOD-H confirmed the colocalization on GFP expressing
E. coli
.